Meanwhile, according to Califano et al. [22], overexpression of HMGA2 has no significant prognostic value for DFS and OS in multivariate analysis; even high HMGA2 expression combined with high body mass index (BMI; ≥25 kg/m2) indicated a poor prognosis in patients with ovarian cancer. This evidence concerns the gene HMGA2 and ovarian cancer.